JP2013534424A5 - - Google Patents

Download PDF

Info

Publication number
JP2013534424A5
JP2013534424A5 JP2013518760A JP2013518760A JP2013534424A5 JP 2013534424 A5 JP2013534424 A5 JP 2013534424A5 JP 2013518760 A JP2013518760 A JP 2013518760A JP 2013518760 A JP2013518760 A JP 2013518760A JP 2013534424 A5 JP2013534424 A5 JP 2013534424A5
Authority
JP
Japan
Prior art keywords
strand
nucleotides
dsrna
less
isolated
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2013518760A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013534424A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/042810 external-priority patent/WO2012006241A2/en
Publication of JP2013534424A publication Critical patent/JP2013534424A/ja
Publication of JP2013534424A5 publication Critical patent/JP2013534424A5/ja
Pending legal-status Critical Current

Links

JP2013518760A 2010-07-06 2011-07-01 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物 Pending JP2013534424A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36175910P 2010-07-06 2010-07-06
US61/361,759 2010-07-06
PCT/US2011/042810 WO2012006241A2 (en) 2010-07-06 2011-07-01 Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna

Publications (2)

Publication Number Publication Date
JP2013534424A JP2013534424A (ja) 2013-09-05
JP2013534424A5 true JP2013534424A5 (OSRAM) 2014-08-14

Family

ID=45441760

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013518760A Pending JP2013534424A (ja) 2010-07-06 2011-07-01 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物

Country Status (6)

Country Link
US (2) US8927515B2 (OSRAM)
EP (1) EP2591104A4 (OSRAM)
JP (1) JP2013534424A (OSRAM)
AU (1) AU2011276363A1 (OSRAM)
CA (1) CA2804210A1 (OSRAM)
WO (1) WO2012006241A2 (OSRAM)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100048912A1 (en) 2008-03-14 2010-02-25 Angela Brodie Novel C-17-Heteroaryl Steroidal CYP17 Inhibitors/Antiandrogens, In Vitro Biological Activities, Pharmacokinetics and Antitumor Activity
EP3062106B1 (en) 2008-04-16 2020-11-11 The Johns Hopkins University Method for determining androgen receptor variants in prostate cancer
AR092982A1 (es) * 2012-10-11 2015-05-13 Isis Pharmaceuticals Inc Modulacion de la expresion de receptores androgenicos
KR20150095763A (ko) * 2012-12-14 2015-08-21 다이서나 파마수이티컬, 인크. 이중쇄 rna에 의한 ckap5의 특이적 저해를 위한 방법 및 조성물
WO2014153215A1 (en) 2013-03-14 2014-09-25 University Of Maryland,Baltimore Office Of Technology Transfer Androgen receptor down-regulating agents and uses thereof
PL3444350T3 (pl) 2013-07-03 2022-03-21 Dicerna Pharmaceuticals, Inc. Sposoby i kompozycje do specyficznego hamowania alfa-1 antytrypsyny przez dwuniciowy rna
WO2015023710A1 (en) 2013-08-12 2015-02-19 Tokai Pharmaceuticals, Inc. Biomarkers for treatment of neoplastic disorders using androgen-targeted therapies
EP3146081B1 (en) 2014-05-19 2020-10-28 The Johns Hopkins University Methods for identifying androgen receptor splice variants in subjects having castration resistant prostate cancer
CA2959336A1 (en) * 2014-08-25 2016-03-03 The Johns Hopkins University Methods and compositions related to prostate cancer therapeutics
AU2015367378A1 (en) 2014-12-17 2017-06-15 Proqr Therapeutics Ii B.V. Targeted RNA editing
BR112018001988A2 (pt) 2015-07-30 2018-09-11 Bayer Cropscience Ag métodos e composições para o controle de fungos de ferrugem através da inibição de expressão do gene hxt1
MA45340A (fr) * 2016-04-01 2019-02-06 Avidity Biosciences Llc Acides nucléiques du récepteur des androgènes et leurs utilisations
CN109477103A (zh) 2016-06-22 2019-03-15 ProQR治疗上市公司Ⅱ 单链rna-编辑寡核苷酸
WO2018041973A1 (en) * 2016-09-01 2018-03-08 Proqr Therapeutics Ii B.V. Chemically modified single-stranded rna-editing oligonucleotides
AU2017368050A1 (en) 2016-11-29 2019-06-20 Puretech Lyt, Inc. Exosomes for delivery of therapeutic agents
WO2018134301A1 (en) 2017-01-19 2018-07-26 Proqr Therapeutics Ii B.V. Oligonucleotide complexes for use in rna editing
KR102321426B1 (ko) 2017-02-21 2021-11-05 올릭스 주식회사 남성형 탈모 표적 유전자의 발현을 억제하는 비대칭 siRNA
EP3755814B1 (en) * 2018-02-23 2025-04-09 Cornell University Assay for detection of androgen receptor variants
CN112020557B (zh) 2018-03-27 2025-02-11 罗切斯特大学 用于假尿苷化的核酸分子
GB201808146D0 (en) 2018-05-18 2018-07-11 Proqr Therapeutics Ii Bv Stereospecific Linkages in RNA Editing Oligonucleotides
KR102473989B1 (ko) * 2018-11-28 2022-12-07 (주)바이오니아 안드로젠 수용체 특이적 서열을 포함하는 이중나선 올리고뉴클레오티드 구조체, 및 이를 포함하는 탈모 예방 및 발모용 조성물
WO2025160224A1 (en) * 2024-01-24 2025-07-31 Arrowhead Pharmaceuticals, Inc. Rnai agents for inhibiting expression of androgen receptor (ar), compositions thereof, and methods of use
WO2025226946A1 (en) * 2024-04-24 2025-10-30 Cedric Francois Methods and compositions for the treatment of androgenic alopecia
WO2025254047A1 (ja) * 2024-06-06 2025-12-11 東亞合成株式会社 アンドロゲン受容体 rna配列に基づく新規二本鎖rna及びその利用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050170371A1 (en) * 2001-05-18 2005-08-04 Sirna Therapeutics, Inc. RNA interference mediated inhibition of 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
DK2284266T3 (da) * 2002-11-14 2014-01-13 Thermo Fisher Scient Biosciences Inc sIRNA-MOLEKYLE MOD TP53
US20060257851A1 (en) * 2002-11-26 2006-11-16 Itzhak Bentwich Bioinformatically detectable group of novel viral regulatory genes and uses thereof
US20050164970A1 (en) * 2003-12-22 2005-07-28 University Of Kansas Medical Center Method for treating prostate cancer using siRNA duplex for androgen receptor
WO2005089287A2 (en) * 2004-03-15 2005-09-29 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded rna
US20070265220A1 (en) 2004-03-15 2007-11-15 City Of Hope Methods and compositions for the specific inhibition of gene expression by double-stranded RNA
JP4961549B2 (ja) * 2006-02-16 2012-06-27 国立大学法人愛媛大学 アンドロゲン受容体遺伝子に特異的なsiRNA
US20080014584A1 (en) * 2006-06-01 2008-01-17 Mayo Foundation For Medical Education And Research Modulating androgen receptor activity

Similar Documents

Publication Publication Date Title
JP2013534424A5 (OSRAM)
JP2013534425A5 (OSRAM)
JP7109416B2 (ja) 二本鎖rnaによるグリコール酸オキシダーゼ(hao1)の特異的阻害に関する方法および組成物
JP6453275B2 (ja) 非対称性干渉rnaの組成物およびその使用
JP2023123743A (ja) GST-π遺伝子を調節するためのRNA干渉剤
JP2007529224A5 (OSRAM)
RU2013148024A (ru) Композиции и способы ингибирования экспрессии гена tmprss6
US20110190382A1 (en) Treatment of Cancer by Inhibition of IGFBPs and Clusterin
SG170780A1 (en) Compositions and methods for inhibiting expression of eg5 gene
SG171676A1 (en) Compositions and methods for inhibiting expression of the pcsk9 gene
WO2008109452B1 (en) Nucleic acid compounds for inhibiting tie gene expression and uses thereof
JP2009536827A5 (OSRAM)
JP2013534424A (ja) 二本鎖rnaによるアンドロゲン受容体の特異的阻害に対する方法と化合物
CN105008533A (zh) 嵌合单链反义多核苷酸和双链反义试剂
JP2010532163A5 (OSRAM)
CN102719432B (zh) 特异性抑制肿瘤凋亡抑制基因Bcl2的双链不对称小核酸干扰分子asiRNA及其应用
JP2022031642A (ja) アンチセンスオリゴヌクレオチド
JP7086039B2 (ja) NOTCH 1特異的なsiRNA分子
US11118184B2 (en) Asymmetric siRNA for inhibiting expression of male pattern hair loss target gene
JP2007530431A5 (OSRAM)
EP2064328B1 (en) Sensitization of cancer cells to therapy using sina targeting genes from the 1p and 19q chromosomal regions
KR101993377B1 (ko) Bcl2 유전자 및 bi-1 유전자의 발현을 동시에 억제하는 핵산
CN107709561A (zh) 修饰的siRNA及含有该修饰的siRNA的药物组合物
CN101173275B (zh) 抑制sars冠状病毒m蛋白基因表达的小干扰rna及其编码基因与应用
JPWO2022212231A5 (OSRAM)